Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen P Finn

Showing results (31-40 of 111) with videos related to

Pageof 12
Sort By:
Frontiers in Oncology|July 16, 2026
Homologous recombination repair and breast cancer gene testing in prostate cancer: expert perspectives and practical guidance on best practice from sample acquisition to biomarker-informed clinical decision-makingEva Compérat, Gunhild von Amsberg, Lynda Corrigan, et al.
Cancer Letters|January 23, 2016
Lung cancer stem cells: The root of resistanceLauren MacDonagh, Steven G Gray, Eamon Breen, et al.
Cancer Letters|April 14, 2018
BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLCLauren MacDonagh, Steven G Gray, Eamon Breen, et al.
International Journal of Oncology|January 20, 2016
KAT5 (Tip60) is a potential therapeutic target in malignant pleural mesotheliomaSian Cregan, Lauran McDonagh, Yun Gao, et al.
Diagnostics (Basel, Switzerland)|August 27, 2021
Deep Learning of Histopathological Features for the Prediction of Tumour Molecular GeneticsPierre Murchan, Cathal Ó'Brien, Shane O'Connell, et al.
Translational Oncology|February 7, 2021
Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatinLauren MacDonagh, Rhyla Mae Santiago, Steven G Gray, et al.
Diagnostics (Basel, Switzerland)|September 12, 2018
RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer-From Cell Line Models to Liquid BiopsiesMarvin C J Lim, Anne-Marie Baird, John Aird, et al.
Journal of Nanobiotechnology|March 9, 2021
Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small-molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroidsEzgi Oner, Mustafa Kotmakci, Anne-Marie Baird, et al.
Cancer Biology & Therapy|July 16, 2014
Strategic targeting of the PI3K-NFκB axis in cisplatin-resistant NSCLCSusan Heavey, Peter Godwin, Anne-Marie Baird, et al.
Head & Neck|February 14, 2006
Distinct array comparative genomic hybridization profiles in oral squamous cell carcinoma occurring in young patientsEsther M O'Regan, Mary E Toner, Paul C Smyth, et al.
Pageof 12

Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
Frontiers in Oncology|July 16, 2026
Homologous recombination repair and breast cancer gene testing in prostate cancer: expert perspectives and practical guidance on best practice from sample acquisition to biomarker-informed clinical decision-makingEva Compérat, Gunhild von Amsberg, Lynda Corrigan, et al.
Cancer Letters|January 23, 2016
Lung cancer stem cells: The root of resistanceLauren MacDonagh, Steven G Gray, Eamon Breen, et al.
Cancer Letters|April 14, 2018
BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLCLauren MacDonagh, Steven G Gray, Eamon Breen, et al.
International Journal of Oncology|January 20, 2016
KAT5 (Tip60) is a potential therapeutic target in malignant pleural mesotheliomaSian Cregan, Lauran McDonagh, Yun Gao, et al.
Diagnostics (Basel, Switzerland)|August 27, 2021
Deep Learning of Histopathological Features for the Prediction of Tumour Molecular GeneticsPierre Murchan, Cathal Ó'Brien, Shane O'Connell, et al.
Translational Oncology|February 7, 2021
Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatinLauren MacDonagh, Rhyla Mae Santiago, Steven G Gray, et al.
Diagnostics (Basel, Switzerland)|September 12, 2018
RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer-From Cell Line Models to Liquid BiopsiesMarvin C J Lim, Anne-Marie Baird, John Aird, et al.
Journal of Nanobiotechnology|March 9, 2021
Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small-molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroidsEzgi Oner, Mustafa Kotmakci, Anne-Marie Baird, et al.
Cancer Biology & Therapy|July 16, 2014
Strategic targeting of the PI3K-NFκB axis in cisplatin-resistant NSCLCSusan Heavey, Peter Godwin, Anne-Marie Baird, et al.
Head & Neck|February 14, 2006
Distinct array comparative genomic hybridization profiles in oral squamous cell carcinoma occurring in young patientsEsther M O'Regan, Mary E Toner, Paul C Smyth, et al.
Pageof 12